Bruce Cranna Quotes (4 Quotes)

Most people in cardiology would say that more is better. If Abbott does acquire the Guidant business, there's very little overlap. There's probably not a lot of restructuring to come.

It's a classic situation of expectations getting ahead of the story.

As drug classes go, growth rates in anti-psychotics are actually quite healthy. But it's fairly well penetrated. It gets harder to grow as the industry gets bigger.

It looks like they kind of scraped by. Earnings were in line. Sales were a bit light, mostly on the drug side of the business. It's nothing to jump up and down about.